<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02361671</url>
  </required_header>
  <id_info>
    <org_study_id>UHN REB # 14-8172</org_study_id>
    <nct_id>NCT02361671</nct_id>
  </id_info>
  <brief_title>Optic Nerve Sheath Diameter in Patients With Intracranial Pathology</brief_title>
  <official_title>Ultrasonographic Assessment of the Optic Nerve Sheath Diameter in Patients With Intracranial Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Elevated intracranial pressure (ICP) is a common and potentially life threatening condition&#xD;
      arising from a variety of pathological conditions. The ability to monitor ICP is a crucial&#xD;
      aspect in the management of these patients. Currently, the diagnosis of whether ICP is&#xD;
      elevated or not is determined either with clinical signs (headache, nausea and vomiting or&#xD;
      visual disturbances) or from the changes in the preoperative neuroimaging modalities such as&#xD;
      computerized tomography (CT scan) and/or magnetic resonance imaging (MRI).&#xD;
&#xD;
      Recently, transorbital ultrasonography has gained popularity as a noninvasive bedside exam&#xD;
      that has been shown to be useful in the diagnosis of raised ICP by evaluating the change in&#xD;
      the optic nerve sheath diameter (ONSD).&#xD;
&#xD;
      The aim of our study is to use transorbital ultrasound to evaluate ONSD changes in patients&#xD;
      with intracranial pathology and to compare the changes in the ONSD before and after surgical&#xD;
      intervention as well as between patients with and without clinical or radiological signs of&#xD;
      increased ICP.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Optic Nerve Sheath Diameter, as measured by ultrasound of the optic nerve&quot;</measure>
    <time_frame>upto 6-8 weeks</time_frame>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Elevated Intracranial Pressure (ICP)</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optic Nerve Sheath Diameter using an ultrasound</intervention_name>
    <description>Optic nerve sheath diameter will be measured by ultrasound preoperatively on the day of surgery, Immediate postoperative period (within 24 hours) or 6-8 weeks after surgery on the follow-up visit.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Intracranial pathology patients scheduled for elective or emergency surgery.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Intracranial pathology patients scheduled for elective or emergency surgery.&#xD;
&#xD;
          -  American Anesthesiologist Society physical status classification system (ASA) 1-4&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of Glaucoma,&#xD;
&#xD;
          -  previous retinal surgery,&#xD;
&#xD;
          -  optic neuritis,&#xD;
&#xD;
          -  lack of informed consent,&#xD;
&#xD;
          -  pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 3, 2015</study_first_submitted>
  <study_first_submitted_qc>February 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2015</study_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Health Network, Toronto</investigator_affiliation>
    <investigator_full_name>Michael Dinsmore</investigator_full_name>
    <investigator_title>Staff Anesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

